Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-23-011737

Chief Executive Officer bought 1,700 shares at an average $3.46 ($5,876)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vitoc Vlad Chief Executive Officer 2023-03-30 Purchase 10b5-1 +205 $3.43 $703 801,326 D: show line 1 in the form
Vitoc Vlad Chief Executive Officer 2023-03-31 Purchase 10b5-1 +1,495 $3.46 $5,173 802,821 D: show line 2 in the form
Open-market purchases · 1,700 sh · avg $3.46 · $5,876
Loading xslF345X04/form4.xml…